Omicron infections have a lower risk of long COVID than earlier variants, according to a study analyzing data from 11,000 participants.
The risk of developing long COVID is significantly lower following an infection with the Omicron variant than after an infection with earlier coronavirus variants. This was the finding of a study by University Medicine Halle, which was published in the International Journal of Infectious Diseases.
The analysis looked at information gathered from 11,000 people about their infection history, vaccination status, and post-infection symptoms. The data provide strong evidence that the risk for long-term effects after a re-infection with the coronavirus is lower if the patient did not develop long COVID after the initial infection.
Understanding Long COVID and its Relation to Variants
Long-term symptoms can develop after a coronavirus infection. This is commonly referred to as "long COVID" or "Post COVID-19 condition." The underlying risk factors are currently under intensive investigation.
"We wanted to understand the connection between long COVID and different coronavirus variants, vaccinations, and past infections," explains Sophie Diexer, first author of the new study and researcher at the Institute of Medical Epidemiology, Biometry and Informatics at University Medicine Halle. "Our study shows that the percentage of people who develop long COVID symptoms after an infection was lowest at the time when Omicron was prevalent."
The risk was found to be around three to four times lower after an Omicron infection than after an infection with the wild-type variant. Around half of all wild-type infected individuals reported persisting symptoms. It should be noted, however, that the majority of all infections occurred while Omicron was dominant. "In purely numerical terms, this means that most people developed long COVID following an Omicron infection," says Diexer.
Recovery and Reduced Risk
The study also provides strong evidence of a protective effect once the patient has recovered from a coronavirus infection. "People who did not develop persistent symptoms after their initial infection had a significantly lower risk of developing long COVID following re-infection than people who were infected with the coronavirus for the first time. We were surprised by the scale of this effect," explains the researcher.
However, the scientists were unable to demonstrate that, in the event of a vaccine breakthrough, the vaccine had any protective effect against long COVID. Due to the timing of the study, however, it was not possible to analyze the vaccine that specifically targeted the Omicron variant.
Details and Background of the Study
The study is based on the Germany-wide DigiHero project, which more than 48,000 people participated in until June 2022. "Studies have already looked at the relationship between the risk of long COVID and the different variants, but none has taken into account infection history," explains Professor Rafael Mikolajczyk, director of the Institute of Medical Epidemiology, Biometry and Informatics at University Medicine Halle.
"Of the respondents, approximately 11,000 reported at least one coronavirus infection that had occurred in the twelve weeks prior to when the data was collected for our study. Classification was based on the predominant variant at the time of the reported infection."
Participants were questioned about 24 typical long COVID symptoms, with 2,822 individuals reporting that they had experienced such symptoms. Of these, 406 (14 percent) reported experiencing severe fatigue, 237 (8 percent ) severe headaches, and 202 (7 percent) severe shortness of breath. The intensity of the symptoms was not related to the coronavirus variant.
Future Investigations and DigiHero Project
Follow-up surveys are currently being conducted to explore the persistence of long COVID symptoms. "In addition to possible long-term symptoms following a coronavirus infection, DigiHero is addressing a wide range of health issues and other impacts of the COVID-19 pandemic," adds Mikolajczyk.
On the basis of DigiHero, University Medicine Halle has also launched the Long COVID Registry in cooperation with Otto von Guericke University Magdeburg and the Rechts der Isar Hospital of the TUM School of Medicine. The registry records, for example, long COVID symptoms as well as their progression, severity, and alleviation through specific therapies.
Reference: "Association between Virus Variants, Vaccination, Previous Infections, and Post COVID-19 Risk" by Sophie Diexer, Bianca Klee, Cornelia Gottschick, Chao Xu, Anja Broda, Oliver Purschke, Mascha Binder, Thomas Frese, Matthias Girndt, Jessica I. Hoell, Irene Moor, Michael Gekle and Rafael Mikolajczyk, 25 August 2023, International Journal of Infectious Diseases.
DOI: 10.1016/j.ijid.2023.08.019
DigiHero is a Germany-wide, population-based digital health research study. To date, over 90,000 people from 14 German states have registered. Participants are invited to complete online surveys that explore issues surrounding the development of chronic disease, healthy aging, health behaviors, and the coronavirus. Five clinics and four institutes from University Medicine Halle are taking part. Other project partners include Jena University Hospital, the Leibniz Institute for Prevention Research and Epidemiology – BIPS, and the University of Bremen.
News
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
